MET and intrahepatic cholangiocarcinoma: Unlike myCAF, iCAF is enriched in early stage ICC and promotes ICC development through the hepatocyte growth factor (HGF)-MET (HGF receptor) axis as a key tumor-promoting ligand–receptor pair, directly linking iCAF to tumor cells via ERK-mediated tumor cell proliferation (21).